Matt Gline is back with a new ‘vant’ company, after the Roivant Sciences CEO paid Bayer $14 million upfront for the rights to a phase 2-ready pulmonary hypertension drug. The asset in question, ...
Roivant Sciences ROIV announced the formation of a new Vant company with Pfizer PFE to advance the development of PF-06480605, a TL1A-directed antibody originally developed by Pfizer, for treating ...
Roivant Sciences Ltd.'s Vant model gives it risk-isolated development, monetization flexibility, and diversified optionality. ROIV's main value drivers are Immunovant, Priovant, Pulmovant, and ...
“I’m down, I’m tired, I’m broke, I wanted something more”. There goes Mattie Vant, frontman of indie rock band VANT, casually summing up 21st century life in 10 words. It’s something they do with ease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results